PortfoliosLab logoPortfoliosLab logo
CAPR vs. KEEL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAPR vs. KEEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Capricor Therapeutics, Inc. (CAPR) and Keel Infrastructure Corporation (KEEL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CAPR achieves a -9.36% return, which is significantly lower than KEEL's 140.85% return.


CAPR

1D
-2.06%
1M
-13.89%
YTD
-9.36%
6M
-8.40%
1Y
83.84%
3Y*
77.22%
5Y*
42.20%
10Y*
-2.03%

KEEL

1D
10.33%
1M
42.57%
YTD
140.85%
6M
94.50%
1Y
530.92%
3Y*
73.17%
5Y*
5.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CAPR vs. KEEL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CAPR
Capricor Therapeutics, Inc.
-9.36%109.13%182.21%26.68%31.74%-14.58%167.97%-68.78%-64.35%
KEEL
Keel Infrastructure Corporation
140.85%57.72%-48.80%561.36%-91.29%165.79%397.66%-27.96%-64.19%

Correlation

The correlation between CAPR and KEEL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Aug 29, 2018

0.17

Fundamentals

Market Cap

CAPR:

$1.50B

KEEL:

$3.12B

EPS

CAPR:

-$2.32

KEEL:

-$0.51

PB Ratio

CAPR:

0.01

KEEL:

5.57

Total Revenue (TTM)

CAPR:

$0.00

KEEL:

$229.28M

Gross Profit (TTM)

CAPR:

-$42.41M

KEEL:

-$18.90M

EBITDA (TTM)

CAPR:

-$117.24M

KEEL:

-$149.60M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAPR vs. KEEL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAPR
CAPR Risk / Return Rank: 7575
Overall Rank
CAPR Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
CAPR Sortino Ratio Rank: 9797
Sortino Ratio Rank
CAPR Omega Ratio Rank: 9696
Omega Ratio Rank
CAPR Calmar Ratio Rank: 6767
Calmar Ratio Rank
CAPR Martin Ratio Rank: 6464
Martin Ratio Rank

KEEL
KEEL Risk / Return Rank: 9595
Overall Rank
KEEL Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
KEEL Sortino Ratio Rank: 9595
Sortino Ratio Rank
KEEL Omega Ratio Rank: 9393
Omega Ratio Rank
KEEL Calmar Ratio Rank: 9696
Calmar Ratio Rank
KEEL Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CAPR vs. KEEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Capricor Therapeutics, Inc. (CAPR) and Keel Infrastructure Corporation (KEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CAPRKEELDifference
Sharpe ratioReturn per unit of total volatility

-4.63

Sortino ratioReturn per unit of downside risk

+0.53

Omega ratioGain probability vs. loss probability

1.59

1.47

+0.12

Calmar ratioReturn relative to maximum drawdown

1.26

7.27

-6.01

Martin ratioReturn relative to average drawdown

2.38

12.09

-9.71

CAPR vs. KEEL - Sharpe Ratio Comparison

The current CAPR Sharpe Ratio is 0.22, which is lower than the KEEL Sharpe Ratio of 4.85. The chart below compares the historical Sharpe Ratios of CAPR and KEEL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CAPRKEELDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.22

4.85

-4.63

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.22

0.05

+0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.08

0.07

-0.15

Drawdowns

CAPR vs. KEEL - Drawdown Comparison

The maximum CAPR drawdown since its inception was -99.97%, roughly equal to the maximum KEEL drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for CAPR and KEEL.


Loading charts...

Drawdown Indicators


CAPRKEELDifference

Max Drawdown

Largest peak-to-trough decline

-99.97%

-95.72%

-4.25%

Max Drawdown (1Y)

Largest decline over 1 year

-67.00%

-73.65%

+6.65%

Max Drawdown (3Y)

Largest decline over 3 years

-79.08%

-81.04%

+1.96%

Max Drawdown (5Y)

Largest decline over 5 years

-79.08%

-95.72%

+16.64%

Max Drawdown (10Y)

Largest decline over 10 years

-98.02%

Current Drawdown

Current decline from peak

-99.20%

-36.19%

-63.01%

Average Drawdown

Average peak-to-trough decline

-90.24%

-67.60%

-22.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.96%

44.21%

-8.25%

Volatility

CAPR vs. KEEL - Volatility Comparison

The current volatility for Capricor Therapeutics, Inc. (CAPR) is 18.21%, while Keel Infrastructure Corporation (KEEL) has a volatility of 28.39%. This indicates that CAPR experiences smaller price fluctuations and is considered to be less risky than KEEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CAPRKEELDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.21%

28.39%

-10.18%

Volatility (6M)

Calculated over the trailing 6-month period

50.01%

70.46%

-20.45%

Volatility (1Y)

Calculated over the trailing 1-year period

385.34%

110.59%

+274.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

190.06%

105.02%

+85.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

179.86%

291.45%

-111.59%

Dividends

CAPR vs. KEEL - Dividend Comparison

Neither CAPR nor KEEL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CAPR vs. KEEL - Financials Comparison

This section allows you to compare key financial metrics between Capricor Therapeutics, Inc. and Keel Infrastructure Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M202220232024202520260
15.38M
(CAPR) Total Revenue
(KEEL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CAPR and KEEL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KEEL has higher volatility (28.39%) compared to CAPR (18.21%). In terms of maximum drawdown, CAPR dropped -99.97% vs KEEL's -95.72%.

KEEL currently has the higher Sharpe Ratio (4.85 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CAPR and KEEL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer